Allergen immunotherapy, also known as “allergy shots”, is a form of long-term treatment that decreases symptoms for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy.
- Advertising -
Allergy shots decrease sensitivity to allergens that’s why it is known as “desensitization or hypo-sensitization” and often lead to lasting relief of allergy symptoms even after treatment is stopped.
Complete report available at www.marketreportsonline.com/431698.html.
This makes it a cost-effective, beneficial treatment approach for many people.
- Advertising -
Whole allergen immunotherapy is the only treatment that targets the actual cause of the allergy and attempts to re-educate the immune system to tolerate the allergen.
In the 2013 ‘World Allergy Organization White Book’, the WHO estimated that there were 400 million people in the world suffering from allergic rhinitis and 300 million from asthma, which shows the scale of the problem. The most common allergens found in the US and Europe.
Patients presenting with allergies are questioned and the tested in an attempt to ascertain exactly what they are allergic to. Once this has been identified, a treatment regime can be put in place.
However, the approaches in the US and Europe are quite different, largely because of differences in product availability. The type of product used falls into three categories: SCIT, SLITD and SLITT.
Access a copy of this “Allergy Immunotherapy Market” research report at http://www.marketreportsonline.com/contacts/purchase.php?name=431698.
The report titled “Global Allergy Immunotherapy Market” provides an in-depth analysis of the global allergy immunotherapy market with detailed analysis of market sizing and growth, market share and economic impact of the industry. Global allergy immunotherapy market penetration rate is also provided in the report.
The report also provides market size of allergic rhino conjunctivitis (AR) and HDM allergy disease. The report provides detailed market share analysis of the global allergy immunotherapy market by types, regions and players.
The market share of allergy immunotherapy market in the respiratory market and prescription allergy market is also explained in detailed.
The report provides detail regional analysis of the allergy immunotherapy market in the United States and Europe. In regional analysis market by value, key players are provided with market for pipeline products.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global allergy immunotherapy market has also been forecasted for the period 2014-2019, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The competition is global allergy immunotherapy market is stiff and dominated by the big players like ALK-Abello. Further, key players of the allergy immunotherapy industry like ALK-Abello, Stallergenes; and Allergy Therapeutics are also profiled with their financial information and respective business strategies.
Key Topics Covered:
- Executive Summary
- Global Allergy Therapeutics Market: An Analysis
- Allergy Immunotherapy Market: Regional Analysis
- Market Dynamics
- Competitive Landscape
- Company Profiles
Category: Market Research Publishers and RetailersCompany about: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
For more information: